Crossamerica Partners LP
CAPL · NYSE
About CAPL
- Employees
- 257
- Headquarters
- Allentown, Pennsylvania
- Listed
- Oct 25, 2012
- Sector
- Energy
- Industry
- Oil, Gas & Consumable Fuels
- Website
- crossamericapartners.com
CAPL key statistics
- Market cap
- 827.98M
- Price-earnings ratio
- 15.83
- Dividend yield
- 9.73%
- Average volume
- 28.45K
- Volume
- 14.10K
- Open price
- $21.80
- High today
- $22.01
- Low today
- $21.43
- 52 Week high
- $24.63
- 52 Week low
- $19.78
Crossamerica Partners LP (CAPL) at a glance
As of Oct 20, 2026, Crossamerica Partners LP (CAPL) shares are priced at $21.72, giving the company a market cap of 827.98M, a price-to-earnings ratio of 15.83 and a dividend yield of 9.73%.
Today the stock has traded between $21.43 and $22.01. The current price is 1.4% above the day's low and 1.3% below its high.
Volume so far is 14.10K shares, below the average of 28.45K shares a day.
Over the past year Crossamerica Partners LP has ranged from $19.78 to $24.63, and now sits 40% of the way up that range.
Crossamerica Partners LP met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.52 per share against an estimate of $0.3876.
CAPL earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 315.6% on average.
- Q3 FY24: reported $0.27 per share against an estimate of $0.255
- Q4 FY24: reported $0.42 per share against an estimate of $0.0408
- Q1 FY25: reported -$0.20 per share against an estimate of -$0.0612
- Q2 FY25: reported $0.64 per share against an estimate of $0.204
- Q3 FY25: reported $0.34 per share against an estimate of $0.0714
- Q4 FY25: reported $0.25 per share against an estimate of $0.051
- Q1 FY26: reported $0.26 per share against an estimate of -$0.1632
- Q2 FY26: reported $0.52 per share against an estimate of $0.3876
CAPL news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
CrossAmerica Partners to Announce Second Quarter 2026 Earnings Results on August 5
- Press releaseGlobe Newswire
CrossAmerica Partners to Announce First Quarter 2026 Earnings Results on May 6
What to Expect from CrossAmerica Partners's Earnings
- Press releaseGlobe Newswire
CrossAmerica Partners to Announce Fourth Quarter and Full Year 2025 Earnings Results on February 25
- Press releaseGlobe Newswire
CrossAmerica Partners to Announce Third Quarter 2025 Earnings Results on November 5
- Press releaseGlobe Newswire
CrossAmerica Partners to Announce Second Quarter 2025 Earnings Results on August 6
- Press releaseGlobe Newswire
CrossAmerica Partners to Announce First Quarter 2025 Earnings Results on May 7
Similar companies
Companies in the same industry as Crossamerica Partners LP
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.